U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H27ClN2.C4H4O4
Molecular Weight 470.988
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ZICRONAPINE FUMARATE

SMILES

OC(=O)\C=C\C(O)=O.CN1CCN(CC1(C)C)[C@@H]2C[C@H](C3=CC=C(Cl)C=C23)C4=CC=CC=C4

InChI

InChIKey=PSDXTSHOYHAMTE-VFHZDWIZSA-N
InChI=1S/C22H27ClN2.C4H4O4/c1-22(2)15-25(12-11-24(22)3)21-14-19(16-7-5-4-6-8-16)18-10-9-17(23)13-20(18)21;5-3(6)1-2-4(7)8/h4-10,13,19,21H,11-12,14-15H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t19-,21+;/m0./s1

HIDE SMILES / InChI
Molecular Formula C22H27ClN2
Molecular Weight 354.916
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description

Zicronapine (formerly known as Lu 31-130), an oral antipsychotic that was studied for the treatment of schizophrenia. The drug was used in a phase III clinical trial.

Originator

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.
2013-11
Patents

Patents

20060281758
2
20060281759
3
20080153847
2
20080153848
2
JP2011201924A
2

Sample Use Guides

In Vivo Use Guide
7.5 mg/day
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:17:06 GMT 2025
Edited
by admin
on Mon Mar 31 18:17:06 GMT 2025
Record UNII
354Q3TY534
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(-)-TRANS-4-((1R,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-1,2,2-TRIMETHYLPIPERAZINE HYDROGEN FUMARATE
Preferred Name English
ZICRONAPINE FUMARATE
Common Name English
PIPERAZINE, 4-((1R,3S)-6-CHLORO-2,3-DIHYDRO-3-PHENYL-1H-INDEN-1-YL)-1,2,2-TRIMETHYL-, (2E)-2-BUTENEDIOATE (1:1)
Systematic Name English
Code System Code Type Description
SMS_ID
300000013054
Created by admin on Mon Mar 31 18:17:06 GMT 2025 , Edited by admin on Mon Mar 31 18:17:06 GMT 2025
PRIMARY
FDA UNII
354Q3TY534
Created by admin on Mon Mar 31 18:17:06 GMT 2025 , Edited by admin on Mon Mar 31 18:17:06 GMT 2025
PRIMARY
PUBCHEM
67266632
Created by admin on Mon Mar 31 18:17:06 GMT 2025 , Edited by admin on Mon Mar 31 18:17:06 GMT 2025
PRIMARY
CAS
170381-17-6
Created by admin on Mon Mar 31 18:17:06 GMT 2025 , Edited by admin on Mon Mar 31 18:17:06 GMT 2025
PRIMARY
Related Record Type Details
Structure of ZICRONAPINE
PARENT -> SALT/SOLVATE
Structure of Fumaric acid
PARENT -> SALT/SOLVATE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966